Interestingly, among those genes we find the well-known glioblastoma oncogene EGFR and tumor suppressors CDKN2A and PTEN, but also novel candidates such as KRIT1 and PAOX described in the previous paragraph. This evidence concerns the gene PTEN and glioblastoma.